These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37528457)

  • 1. A synbiotic mixture of selected oligosaccharides and bifidobacteria assists murine gut microbiota restoration following antibiotic challenge.
    Hoedt EC; Hueston CM; Cash N; Bongers RS; Keane JM; van Limpt K; Ben Amor K; Knol J; MacSharry J; van Sinderen D
    Microbiome; 2023 Aug; 11(1):168. PubMed ID: 37528457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Synbiotic on the Gut Microbiota of Cesarean Delivered Infants: A Randomized, Double-blind, Multicenter Study.
    Chua MC; Ben-Amor K; Lay C; Neo AGE; Chiang WC; Rao R; Chew C; Chaithongwongwatthana S; Khemapech N; Knol J; Chongsrisawat V
    J Pediatr Gastroenterol Nutr; 2017 Jul; 65(1):102-106. PubMed ID: 28644357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fermented infant formula (with Bifidobacterium breve C50 and Streptococcus thermophilus O65) with prebiotic oligosaccharides is safe and modulates the gut microbiota towards a microbiota closer to that of breastfed infants.
    Béghin L; Tims S; Roelofs M; Rougé C; Oozeer R; Rakza T; Chirico G; Roeselers G; Knol J; Rozé JC; Turck D
    Clin Nutr; 2021 Mar; 40(3):778-787. PubMed ID: 32893049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of synbiotics on gut microbiota during early life: a randomized, double-blind study.
    Phavichitr N; Wang S; Chomto S; Tantibhaedhyangkul R; Kakourou A; Intarakhao S; Jongpiputvanich S; ; Roeselers G; Knol J
    Sci Rep; 2021 Feb; 11(1):3534. PubMed ID: 33574421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synbiotic mixture of scGOS/lcFOS and Bifidobacterium breve M-16V increases faecal Bifidobacterium in healthy young children.
    Kosuwon P; Lao-Araya M; Uthaisangsook S; Lay C; Bindels J; Knol J; Chatchatee P
    Benef Microbes; 2018 Jun; 9(4):541-552. PubMed ID: 29633642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal Synbiotic Supplementation with
    Sáez-Fuertes L; Kapravelou G; Grases-Pintó B; Bernabeu M; Knipping K; Garssen J; Bourdet-Sicard R; Castell M; Collado MC; Pérez-Cano FJ; Rodríguez-Lagunas MJ
    Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the synbiotic properites of human milk oligosaccharides and Bifidobacterium longum subsp. infantis in vitro and in humanised mice.
    Musilova S; Modrackova N; Hermanova P; Hudcovic T; Svejstil R; Rada V; Tejnecky V; Bunesova V
    Benef Microbes; 2017 Apr; 8(2):281-289. PubMed ID: 28116928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplementation of dietary non-digestible oligosaccharides from birth onwards improve social and reduce anxiety-like behaviour in male BALB/c mice.
    Szklany K; Wopereis H; de Waard C; van Wageningen T; An R; van Limpt K; Knol J; Garssen J; Knippels LMJ; Belzer C; Kraneveld AD
    Nutr Neurosci; 2020 Nov; 23(11):896-910. PubMed ID: 30871432
    [No Abstract]   [Full Text] [Related]  

  • 9. The Impact of Probiotics, Prebiotics, and Synbiotics during Pregnancy or Lactation on the Intestinal Microbiota of Children Born by Cesarean Section: A Systematic Review.
    Martín-Peláez S; Cano-Ibáñez N; Pinto-Gallardo M; Amezcua-Prieto C
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milk oligosaccharide-driven persistence of Bifidobacterium pseudocatenulatum modulates local and systemic microbial metabolites upon synbiotic treatment in conventionally colonized mice.
    Larke JA; Heiss BE; Ehrlich AM; Taft DH; Raybould HE; Mills DA; Slupsky CM
    Microbiome; 2023 Aug; 11(1):194. PubMed ID: 37635250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supplementation of diet with non-digestible oligosaccharides alters the intestinal microbiota, but not arthritis development, in IL-1 receptor antagonist deficient mice.
    Rogier R; Ederveen THA; Wopereis H; Hartog A; Boekhorst J; van Hijum SAFT; Knol J; Garssen J; Walgreen B; Helsen MM; van der Kraan PM; van Lent PLEM; van de Loo FAJ; Abdollahi-Roodsaz S; Koenders MI
    PLoS One; 2019; 14(7):e0219366. PubMed ID: 31283798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial effects of prebiotics, probiotics and synbiotics after Caesarean section or exposure to antibiotics in the first week of life: A systematic review.
    Carpay NC; Kamphorst K; de Meij TGJ; Daams JG; Vlieger AM; van Elburg RM
    PLoS One; 2022; 17(11):e0277405. PubMed ID: 36350926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infant formula containing galacto-and fructo-oligosaccharides and
    Abrahamse-Berkeveld M; Alles M; Franke-Beckmann E; Helm K; Knecht R; Köllges R; Sandner B; Knol J; Ben Amor K; Bufe A
    J Nutr Sci; 2016; 5():e42. PubMed ID: 28620469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of maternal
    Sáez-Fuertes L; Kapravelou G; Grases-Pintó B; Massot-Cladera M; Bernabeu M; Knipping K; Garssen J; Bourdet-Sicard R; Castell M; Rodríguez-Lagunas MJ; Collado MC; Pérez-Cano FJ
    Front Immunol; 2024; 15():1418594. PubMed ID: 38975337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific synbiotics in early life protect against diet-induced obesity in adult mice.
    Mischke M; Arora T; Tims S; Engels E; Sommer N; van Limpt K; Baars A; Oozeer R; Oosting A; Bäckhed F; Knol J
    Diabetes Obes Metab; 2018 Jun; 20(6):1408-1418. PubMed ID: 29460474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synbiotic Effect of
    Marsaux B; Van den Abbeele P; Ghyselinck J; Prioult G; Marzorati M; Bogićević B
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early life gut microbiota profiles linked to synbiotic formula effects: a randomized clinical trial in European infants.
    Lagkouvardos I; Intze E; Schaubeck M; Rooney JP; Hecht C; Piloquet H; Clavel T
    Am J Clin Nutr; 2023 Feb; 117(2):326-339. PubMed ID: 36811568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the gut-lung axis by synbiotic feeding to infants in a randomized controlled trial.
    Sjödin KS; Sjödin A; Ruszczyński M; Kristensen MB; Hernell O; Szajewska H; West CE
    BMC Biol; 2023 Feb; 21(1):38. PubMed ID: 36803508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Supplementation throughout Life with Non-Digestible Oligosaccharides and/or n-3 Poly-Unsaturated Fatty Acids in Healthy Mice Modulates the Gut-Immune System-Brain Axis.
    Szklany K; Engen PA; Naqib A; Green SJ; Keshavarzian A; Lopez Rincon A; Siebrand CJ; Diks MAP; van de Kaa M; Garssen J; Knippels LMJ; Kraneveld AD
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised controlled trial demonstrates that fermented infant formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides reduces the incidence of infantile colic.
    Vandenplas Y; Ludwig T; Bouritius H; Alliet P; Forde D; Peeters S; Huet F; Hourihane J
    Acta Paediatr; 2017 Jul; 106(7):1150-1158. PubMed ID: 28328065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.